nodes	percent_of_prediction	percent_of_DWPC	metapath
Antazoline—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.165	0.19	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0448	0.0518	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0439	0.0507	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0377	0.0435	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0369	0.0426	CbGpPWpGaD
Antazoline—Phentolamine—ADRA2C—attention deficit hyperactivity disorder	0.0292	0.217	CrCbGaD
Antazoline—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0266	0.0307	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0256	0.0296	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0247	0.0286	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0239	0.0277	CbGpPWpGaD
Antazoline—Naphazoline—ADRA2C—attention deficit hyperactivity disorder	0.0238	0.177	CrCbGaD
Antazoline—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0235	0.0272	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0232	0.0269	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0224	0.0258	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0217	0.025	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0208	0.024	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0201	0.0233	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0198	0.0229	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0195	0.0226	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0182	0.021	CbGpPWpGaD
Antazoline—Tolazoline—ADRA2C—attention deficit hyperactivity disorder	0.0172	0.128	CrCbGaD
Antazoline—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0152	0.0175	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0127	0.0147	CbGpPWpGaD
Antazoline—Phentolamine—ADRA2A—attention deficit hyperactivity disorder	0.0125	0.0926	CrCbGaD
Antazoline—Naphazoline—ADRA2A—attention deficit hyperactivity disorder	0.0102	0.0755	CrCbGaD
Antazoline—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.00907	0.0673	CrCbGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00865	0.00999	CbGpPWpGaD
Antazoline—Bepridil—CACNA1C—attention deficit hyperactivity disorder	0.00855	0.0635	CrCbGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00847	0.00979	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00841	0.00972	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00741	0.00856	CbGpPWpGaD
Antazoline—Tolazoline—ADRA2A—attention deficit hyperactivity disorder	0.00735	0.0546	CrCbGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00726	0.00839	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00587	0.00678	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00564	0.00652	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00553	0.00639	CbGpPWpGaD
Antazoline—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00542	0.00626	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00513	0.00593	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00503	0.00581	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00477	0.00551	CbGpPWpGaD
Antazoline—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.00476	0.0353	CrCbGaD
Antazoline—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00475	0.00549	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00462	0.00534	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00454	0.00525	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00449	0.00518	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0044	0.00508	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00432	0.00499	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00418	0.00483	CbGpPWpGaD
Antazoline—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00413	0.0306	CrCbGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00409	0.00472	CbGpPWpGaD
Antazoline—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00405	0.03	CrCbGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00396	0.00457	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00389	0.0045	CbGpPWpGaD
Antazoline—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00387	0.0287	CrCbGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00384	0.00444	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00383	0.00443	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00379	0.00438	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00358	0.00414	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00339	0.00391	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00335	0.00387	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00319	0.00368	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00312	0.00361	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00311	0.0036	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00301	0.00348	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00296	0.00342	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00293	0.00338	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00293	0.00338	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00289	0.00335	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00284	0.00328	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00273	0.00315	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00255	0.00295	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00251	0.0029	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00216	0.0025	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00199	0.0023	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00197	0.00227	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00191	0.00221	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00189	0.00219	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00176	0.00203	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00172	0.00199	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00171	0.00198	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.0017	0.00197	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00168	0.00194	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00167	0.00194	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00165	0.00191	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00164	0.0019	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0016	0.00185	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00155	0.00179	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00154	0.00178	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00152	0.00176	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.0015	0.00174	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0014	0.00162	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00116	0.00134	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00108	0.00125	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00101	0.00117	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00098	0.00113	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000944	0.00109	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000914	0.00106	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000898	0.00104	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000887	0.00103	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000826	0.000955	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000579	0.000669	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000307	0.000354	CbGpPWpGaD
